Type 2 diabetes is a chronic condition that affects millions globally, with significant implications for various organ systems, including the heart, eyes, kidneys and notably, the brain. Recent ...

In people with type 2 diabetes in the world's richest countries, deaths from cardiovascular disease are declining while ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

If your doctor has recently delivered the news of a Type 2 diabetes diagnosis, the wave of emotions – uncertainty, concern, perhaps even fear – is completely understandable. Amidst this whirlwind of ...

Three of the top diabetes tech companies put forward new clinical data this week, making the case for their continuous glucose monitors and insulin pumps as they look to expand their reac | Three ...

(Mass Appeal) – Diabetes, and more specifically type 2 diabetes, is a chronic condition that affects millions of Americans, and now the American Diabetes Association has declared this condition an ...

SPONSORED CONTENT is content paid for by a partner. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. Type 2 diabetes is one of the most common ...

Living with mental-health disorders is challenging enough without adding physical ailments to the mix. But recent research suggests that people with psychiatric disorders also have higher rates of ...

Researchers combined gigapixel microscopy with explainable AI to analyze pancreatic tissue from living donors. The system accurately classified type 2 diabetes and identified structural changes linked ...

At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. those using finger pricking1,2Improvements were participant-led, ...

Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...